Question ID
2014_752
Legal act
Regulation (EU) No 575/2013 (CRR)
Topic
Leverage ratio
Article
Article 9 of CRR
COM Delegated or Implementing Acts/RTS/ITS/GLs/Recommendations
Draft ITS on Supervisory Reporting of Institutions
Article/Paragraph
Cross Form Validation Rules
Name of institution / submitter
Central Bank of Ireland
Country of incorporation / residence
Ireland
Type of submitter
Competent authority
Subject matter
Scope of Waiver for Amended Solo Consolidation and Impact on Supervisory Reporting
Question

Article 9 of Regulation (EU) No 575/2013 (CRR) for the ‘Individual consolidation method’ refers directly to Article 6(1) in terms of the discretion for competent authorities to allow institutions to include certain non-authorised subsidiaries in the scope of their individual returns. In this regard, can we confirm if the 'amended solo' waiver is also available for the Leverage Ratio given that it does not fall under the scope of Article 6(1) i.e. there is no reference to Part Seven of the CRR?

Background on the question

Article 9 of the CRR for the ‘Individual consolidation method’ refers directly to Article 6(1) in terms of the discretion for competent authorities to allow institutions to include certain non-authorised subsidiaries in the scope of their individual returns. In this regard, the current wording of Article 6(1) implies that the amended solo waiver is not available for the Leverage Ratio as it does not fall under the scope of Article 6(1) i.e. there is no reference to Part Seven of the CRR. The wording used in Article 6(5) of the CRR implies that institutions should report the Leverage Ratio on a pure individual basis only, unless they have a derogation under Article 7. If this is the case, then some of the ‘cross form validations’ that exist between the COREP CA/Credit Risk templates and the Leverage Ratio templates will probably fail for institutions that have received permission for amended solo consolidation under Article 9 because the COREP CA/Credit Risk Templates will be reported at amended solo level (i.e. including some non-authorised subsidiaries) and the Leverage Ratio return will be reported at pure solo level (i.e. excluding any non-authorised subsidiaries).

Submission date
Final publishing date
Final answer

The 'amended solo' waiver provided for in Article 9 CRR is not available for the Leverage Ratio given that the Leverage Ratio does not fall under the scope of Article 6(1) Regulation (EU) No 575/2013 (CRR).

Amending the current text of Article 9 CRR to allow an "individual consolidation" for the purpose of the Leverage Ratio so as to ensure an alignment of the level of application between the Own Funds requirements of Part Two and the Leverage Ratio requirements of Part Seven is not envisaged at this stage.  The Commission will consider any necessary changes to the levels of application of CRR requirements in its forthcoming Report to the European Parliament and the Council, due under Article 508(1) CRR.

Any inconsistencies in the reporting validation rules can be addressed by EBA, which could modify the validation rules on cross form validation between the Leverage Ratio reporting templates and the COREP templates, as appropriate. 

DISCLAIMER:

This question goes beyond matters of consistent and effective application of the regulatory framework. A Directorate General of the Commission (Directorate General for Internal Market and Services) has prepared the answer, albeit that only the Court of Justice of the European Union can provide definitive interpretations of EU legislation. This is an unofficial opinion of that Directorate General, which the European Banking Authority publishes on its behalf. The answers are not binding on the European Commission as an institution. You should be aware that the European Commission could adopt a position different from the one expressed in such Q&As, for instance in infringement proceedings or after a detailed examination of a specific case or on the basis of any new legal or factual elements that may have been brought to its attention.

Status
Final Q&A
Answer prepared by
Answer prepared by the European Commission because it is a matter of interpretation of Union law.
Note to Q&A

Update 26.03.2021: This Q&A has not yet been reviewed by the European Commission in the light of the changes introduced to Regulation (EU) No 575/2013 (CRR).

Disclaimer

The Q&A refers to the provisions in force on the day of their publication. The EBA does not systematically review published Q&As following the amendment of legislative acts. Users of the Q&A tool should therefore check the date of publication of the Q&A and whether the provisions referred to in the answer remain the same.